This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
The ceramide-based coronary event risk test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes as well as in those without diabetes. (December 2020)
Record Type:
Journal Article
Title:
The ceramide-based coronary event risk test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes as well as in those without diabetes. (December 2020)
Main Title:
The ceramide-based coronary event risk test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes as well as in those without diabetes